JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus
| Field | Detail |
|---|---|
| Company | Jpmorgan Chase Financial Co. LLC |
| Form Type | 424B2 |
| Filed Date | Mar 24, 2026 |
| Risk Level | low |
| Pages | 11 |
| Reading Time | 13 min |
| Key Dollar Amounts | $5,000,000, $1,000, $2.50, $997.50, $12,500 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: prospectus, debt, capital-raise, corporate-finance
Related Tickers: JPM
TL;DR
**JPM Financial filed a prospectus, likely for a new debt offering, signaling ongoing capital market activity.**
AI Summary
JPMorgan Chase Financial Co. LLC filed a 424B2 prospectus on March 24, 2026, detailing an offering under their existing registration statement 333-270004-01. This filing is a routine update for a financial product, likely a debt offering, issued by JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co. For investors, this indicates ongoing capital market activity by the company, which can impact its financial structure and future earnings, though this specific filing doesn't reveal the terms of the offering.
Why It Matters
This filing indicates JPMorgan Chase Financial Co. LLC is actively raising capital, which can affect its liquidity, debt levels, and ability to fund operations or investments.
Risk Assessment
Risk Level: low — This is a routine prospectus filing for a financial company, indicating standard capital market activity without specific details of a high-risk offering.
Analyst Insight
Investors should note this routine filing as part of JPMorgan Chase's ongoing capital management, but await further details on specific offering terms to assess any direct impact on the stock.
Key Numbers
- 2026-03-24 — Filing Date (Date the 424B2 prospectus was filed by JPMorgan Chase Financial Co. LLC)
- 333-270004-01 — Registration Statement File No. (The specific registration statement under which JPMorgan Chase Financial Co. LLC is offering securities)
Key Players & Entities
- JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus
- JPMORGAN CHASE & CO (company) — Parent company of the filer
- 0001665650 (person) — CIK of JPMorgan Chase Financial Co. LLC
- 0000019617 (person) — CIK of JPMORGAN CHASE & CO
- 333-270004-01 (dollar_amount) — File number for JPMorgan Chase Financial Co. LLC's registration statement
- 333-270004 (dollar_amount) — File number for JPMORGAN CHASE & CO's registration statement
- 2026-03-24 (dollar_amount) — Filing date of the 424B2 prospectus
FAQ
What type of filing is this and who filed it?
This is a 424B2 prospectus filing, submitted by JPMorgan Chase Financial Co. LLC (CIK: 0001665650) on March 24, 2026.
What is the relationship between JPMorgan Chase Financial Co. LLC and JPMORGAN CHASE & CO?
JPMorgan Chase Financial Co. LLC (CIK: 0001665650) is a subsidiary of JPMORGAN CHASE & CO (CIK: 0000019617), as indicated by their respective filing details and the common 'JPMorgan Chase' branding.
Filing Stats: 3,279 words · 13 min read · ~11 pages · Grade level 13.4 · Accepted 2026-03-24 10:34:30
Key Financial Figures
- $5,000,000 — JPMorgan Chase Financial Company LLC $5,000,000 Callable Fixed Rate Notes due March 24
- $1,000 — e purchased in minimum denominations of $1,000 and in integral multiples of $1,000 the
- $2.50 — Proceeds to Issuer Per note $1,000 $2.50 $997.50 Total $5,000,000 $12,500
- $997.50 — ds to Issuer Per note $1,000 $2.50 $997.50 Total $5,000,000 $12,500 $4,987,50
- $12,500 — 00 $2.50 $997.50 Total $5,000,000 $12,500 $4,987,500 (1) The price to the publ
- $4,987,500 — $997.50 Total $5,000,000 $12,500 $4,987,500 (1) The price to the public includes
Filing Documents
- ea0283107-01_424b2.htm (424B2) — 41KB
- ea028310701_ex-filingfees.htm (EX-FILING FEES) — 4KB
- image_001.jpg (GRAPHIC) — 2KB
- 0001213900-26-033287.txt ( ) — 138KB
- ea028310701_ex-filingfees_htm.xml (XML) — 2KB
From the Filing
SUPPLEMENT Pricing supplement To prospectus dated April 13, 2023, prospectus supplement dated April 13, 2023, product supplement no. 1-I dated April 13, 2023 and prospectus addendum dated June 3, 2024 Registration Statement Nos. 333-270004 and 333-270004-01 Dated March 23, 2026 Rule 424(b)(2) JPMorgan Chase Financial Company LLC $5,000,000 Callable Fixed Rate Notes due March 24, 2031 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. General · The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. · These notes are designed for an investor who seeks a fixed income investment at an interest rate of 4.85% per annum but who is also willing to accept the risk that the notes will be called prior to the Maturity Date. · At our option, we may redeem the notes, in whole but not in part, on any of the Redemption Dates specified below. · The notes may be purchased in minimum denominations of $1,000 and in integral multiples of $1,000 thereafter. Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Payment at Maturity: On the Maturity Date, we will pay you the principal amount of your notes plus any accrued and unpaid interest, provided that your notes are outstanding and have not previously been called on any Redemption Date. Call Feature: On the 24 th calendar day of March and September of each year, beginning on March 24, 2027 and ending on September 24, 2030 (each, a “Redemption Date”), we may redeem your notes, in whole but not in part, at a price equal to the principal amount being redeemed plus any accrued and unpaid interest, subject to the Business Day Convention and the Interest Accrual Convention described below and in the accompanying product supplement. If we intend to redeem your notes, we will deliver notice to The Depository Trust Company on any business day after the Original Issue Date that is at least 5 business days before the applicable Redemption Date. Interest: Interest Period, for each $1,000 principal amount note, we will pay you interest in arrears on each Interest Payment Date in accordance with the following formula: $1,000 × Interest Rate × Day Count Fraction. Interest Periods: The period beginning on and including the Original Issue Date and ending on but excluding the first Interest Payment Date, and each successive period beginning on and including an Interest Payment Date and ending on but excluding the next succeeding Interest Payment Date or, if the notes are redeemed prior to that succeeding Interest Payment Date, ending on but excluding the applicable Redemption Date, subject to the Interest Accrual Convention described below and in the accompanying product supplement Interest Payment Dates: Interest on the notes will be payable in arrears on March 24 of each year, beginning on March 24, 2027 to and including the Maturity Date (each, an “Interest Payment Date”), subject to any earlier redemption and the Business Day Convention and Interest Accrual Convention described below and in the accompanying product supplement. Interest Rate: 4.85% per annum Pricing Date: March 23, 2026 Original Issue Date: March 24, 2026, subject to the Business Day Convention (Settlement Date) Maturity Date: March 24, 2031, subject to the Business Day Convention Business Day Convention: Following Interest Accrual Convention: Unadjusted Day Count Convention: 30/360 CUSIP: 46660NAL7 Investing in the notes involves a number of risks. See “Risk Factors” beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk Factors” beginning on page PS-11 of the accompanying product supplement and “Selected Risk Considerations” beginning on page PS-3 of this pricing supplement. Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $2.50 $997.50 Total $5,000,000 $12,500 $4,987,500 (1) The price to the public includes the estimated cost of hedging our obligations under the notes through one or more of our affiliates. (2) J.P. Morgan Securi